Tech Company Financing Transactions

Veradermics Funding Round

Suvretta Capital Management, Connecticut Innovations and private investors invested in a $75 million Series B venture round for Veradermics. This venture round was announced by the company on 12/11/2024.

Transaction Overview

Company Name
Veradermics
Announced On
12/11/2024
Transaction Type
Venture Equity
Amount
$75,000,000
Round
Series B
Investors

Suvretta Capital Management (Lead Investor) (Amanda Birdsey-Benson)

Connecticut Innovations

private investors (Vlad Coric)

Longitude Capital Management (Patrick Enright)

Osage University Partners

PhiFund Ventures

Surveyor Capital

Proceeds Purpose
Proceeds from the financing will be used to fund the ongoing pivotal clinical development of Veradermics' lead candidate VDPHL01 for the treatment of androgenetic alopecia (AGA), or pattern hair loss (PHL), the most common cause of hair loss affecting an estimated 80 million Americans.

Company Information

Company Status
Private & Independent
Industry
Software
Mailing Address
470 James St
New Haven, CT 06470
USA
Phone
Undisclosed
Website
www.veradermics.com
Email Address
[email protected]
Overview
Founded by dermatologists, the company is leveraging its executive team's proven front-line clinical experience to identify and develop innovative therapeutics that address specific patient needs and solve pervasive treatment challenges in dermatology practice. Guided by a steadfast commitment to tackling real-world patient and clinician problems that limit the current standard of care for common skin conditions, Veradermics is acting with urgency to advance a pipeline of diverse, first-in-class, product candidates with demonstrated mechanisms of action.
Profile
Veradermics LinkedIn Company Profile
Social Media
Veradermics Company Twitter Account
Company News
Veradermics News
Facebook
Veradermics on Facebook
YouTube
Veradermics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Reid Waldman
  Reid Waldman LinkedIn Profile  Reid Waldman Twitter Account  Reid Waldman News  Reid Waldman on Facebook
President
Tim Durso
  Tim Durso LinkedIn Profile  Tim Durso Twitter Account  Tim Durso News  Tim Durso on Facebook
VP - Finance
Dominic Carrano
  Dominic Carrano LinkedIn Profile  Dominic Carrano Twitter Account  Dominic Carrano News  Dominic Carrano on Facebook
VP - Manufacturing
Karl Pruss
  Karl Pruss LinkedIn Profile  Karl Pruss Twitter Account  Karl Pruss News  Karl Pruss on Facebook
VP - Operations
Michael Smolinski
  Michael Smolinski LinkedIn Profile  Michael Smolinski Twitter Account  Michael Smolinski News  Michael Smolinski on Facebook
VP - Operations
Barbara Szymaszek
  Barbara Szymaszek LinkedIn Profile  Barbara Szymaszek Twitter Account  Barbara Szymaszek News  Barbara Szymaszek on Facebook
VP - Regulatory Affairs
Aron Shapiro
  Aron Shapiro LinkedIn Profile  Aron Shapiro Twitter Account  Aron Shapiro News  Aron Shapiro on Facebook

 

 

Browse more venture capital transactions:

Prev: 12/11/2024: Ambrosia Biosciences venture capital transaction
Next: 12/11/2024: Finny venture capital transaction

 

Share this article

 

About Database of VC Transactions

We do our best to record every notable VC transaction. All VC database entries reported here are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.